Non-Invasive Medical Diagnostics


Proprietary non-invasive diagnostic technology platform that uses radio waves to identify and measure what is going on inside your body.

Form Factor

A technology platform that can be integrated into a variety of wearable, mobile or bench-top form factors.

100+ Potential Applications

Bio-RFID sensors can identify different molecules in the body, such as glucose, oxygen, alcohol and metabolized drugs.


No needles nor invasive transmitters in your body, making Bio-RFID sensors convenient and pain-free.

No Consumables

Expensive supplies, such as test strips and lancets, are not required to operate Bio-RFID devices.

“The holy grail of the medical industry and patient care.”

James H Anderson Jr., MD, FFPM, FACE
Chief Medical Officer, Know L:abs
Former Senior Medical Director, Diabetes and CardioMetabolic Medicine, Eli Lilly and Company


Know Labs is developing a family of products that can non-invasively identify and measure molecules in your body.

Blood glucose is our first priority. By applying Bio-RFID to non-invasively measure blood glucose, Know Labs can improve how 2 billion people with diabetes and pre-diabetes manage their conditions.


On-demand and On-the-go

Place your palm or hold detachable portion for a spot reading of glucose concentration in mg/dL.

KL_UBAND (1).png

Continuous and Wearable

Put it on your wrist and forget it.
Check your glucose concentration 
through your Know Labs app.

Know Labs is committed to making a difference in the lives of millions of people around the world.

Global Innovator

Leading IP portfolio in the Radio Frequency Spectroscopy space.

Medical Grade Devices

Medical-grade devices with high level of accuracy and seeking FDA clearance.

Affordable Solutions

Expected to be three to five times less expensive than current options.

October 2021

October 2021

August 3, 2022

Know Labs Files S-1 for

New Share Offering,

Seeks Uplist to NYSE

American Exchange

May 24, 2022

Know Labs Expands Leadership Team, Adds Chief Financial Officer and  Chief Product Officer, As It Gets Closer to FDA Clearance Application